David S. Tierney, MD has been appointed president and chief executive officer of Icon Bioscience, Inc. Dr. Tierney is an accomplished healthcare executive with significant experience in successfully developing and commercializing drug delivery platforms. He will apply his expertise to Icon’s Verisome technology platform to develop unique intraocular eye-care therapeutics.   Dr. Tierney previously served as president and chief operating officer of Oceana Therapeutics, Inc., a specialty therapeuti...